Proneuron Biotechnologies
Latest round
- Series B
Last raised
- Jan 2000
Total raised
- Undisclosed
Investors
- 1
About Proneuron Biotechnologies
Founded in 1996 by Dale Miller in New York, US, Proneuron Biotechnologies specializes in neurotechnology solutions. The company has undergone strategic pivots but remains focused on its core mission of improving neurological health.43 mn Grant from The Michael J.com specializes in providing solutions aimed at enhancing neurotechnology and brain health. The company offers a range of innovative products designed to address various neurological conditions and improve cognitive function. Their core offerings include advanced neurostimulation devices that leverage proprietary technology to target specific areas of the brain, providing therapeutic benefits for users suffering from disorders such as depression, anxiety, and chronic pain. These devices are tailored for both individual consumers and medical professionals, allowing them to incorporate advanced treatment options into their practices.com generates revenue through direct-to-consumer sales and partnerships with healthcare providers. The company's structure is built around the sale of its neurostimulation devices, offered through pricing plans that include one-time purchases or subscription models for ongoing support. Transactions typically occur through their online platform or authorized retailers.Proneuron Biotechnologies is focused on expanding its product lineup and entering new markets. The company plans to design and launch new neurostimulation devices within the next 12-18 months, targeting regions in Asia and South America for geographical expansion by 2025. Fox Foundation will be utilized to support these product development initiatives and market entry strategies.
Who invested in Proneuron Biotechnologies
1 investor across 1 round
See all investors in Proneuron Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 1, 2000
Amount
Undisclosed
Investors
Questions about Proneuron Biotechnologies
Who invested in Proneuron Biotechnologies?
Proneuron Biotechnologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proneuron Biotechnologies raised?
Proneuron Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proneuron Biotechnologies last raise money?
Proneuron Biotechnologies's most recent round on record is a Series B, in Jan 2000.
What does Proneuron Biotechnologies do?
Founded in 1996 by Dale Miller in New York, US, Proneuron Biotechnologies specializes in neurotechnology solutions.
Where is Proneuron Biotechnologies headquartered?
Proneuron Biotechnologies is headquartered in New York, US.
Which VCs invest in companies like Proneuron Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Proneuron Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Proneuron Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.